Company Filing History:
Years Active: 2008
Title: The Innovations of Eduardo Stragliotto
Introduction
Eduardo Stragliotto is a notable inventor based in Milan, Italy. He has made significant contributions to the field of medical science, particularly in the treatment of heart diseases. His innovative approach focuses on the therapeutic use of essential fatty acids.
Latest Patents
Stragliotto holds a patent for a method of therapeutic prevention and treatment of heart disease, specifically targeting cardiac insufficiency and heart failure. The patent, titled "Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy," involves the administration of a mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester (DHA). This method can be used alone or in combination with other therapeutic agents, showcasing his commitment to advancing heart health.
Career Highlights
Stragliotto is currently associated with Pfizer Italia S.r.l., a leading pharmaceutical company. His work at Pfizer has allowed him to collaborate with other experts in the field, further enhancing his research and development efforts. His dedication to innovation in medical treatments has positioned him as a key figure in the industry.
Collaborations
Some of his notable coworkers include Francesco Granata and Franco Pamparana. Their collaboration has contributed to the advancement of research in cardiovascular therapies, fostering an environment of innovation and shared knowledge.
Conclusion
Eduardo Stragliotto's contributions to the field of heart disease treatment through his innovative patent demonstrate his expertise and commitment to improving patient outcomes. His work continues to inspire advancements in medical science.